Ocugen files Section 205 petition to validate share increase; hearing set for May 6, 2026

Ocugen, Inc.

Petition seeks validation of Charter Amendment increasing authorized common shares from 295M to 390M, approved at June 2024 annual meeting.
Putative class action challenged voting rights of Series C Preferred Stock used to approve amendment; plaintiff does not oppose petition.
Company filed Certificate of Correction to clarify Series C Preferred voting powers; hearing on petition set for May 6, 2026.
As of Jan 22, 2026, Ocugen had issued 33M shares in reliance on the amendment, all subject to validation.
If petition granted, stockholder action will be mooted; Delaware Chancery Court to decide.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.